Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,346,441
-$3,753,160 QoQ
Shares Held
69,266
-18.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026&PARTNERS holds $136,442,788 across 21 Medical Devices names. BSX ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
576,145 | $59,152,807 | |
| 2 | MDT |
Medtronic plc
|
468,613 | $40,605,316 | |
| 3 | SYK |
Stryker Corp
|
55,491 | $18,233,787 | |
| 4 | BSX |
Boston Scientific Corp
This page
|
69,266 | $4,346,441 | |
| 5 | EW |
Edwards Lifesciences Corp
|
24,525 | $1,963,962 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
21,527 | $1,946,471 | |
| 7 | SNN |
Smith & Nephew PLC
|
58,912 | $1,872,223 | |
| 8 | DXCM |
Dexcom Inc
|
21,076 | $1,323,572 |
All Filings in BSX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,346,441 | 69,266 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,099,601 | 84,946 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,380,046 | 75,592 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,251,799 | 58,205 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,650,894 | 56,016 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,558,803 | 51,039 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,039,258 | 36,268 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $755,622 | 9,812 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $343,545 | 5,016 | Shares | Sole | 2024-04-11 | |
| No filing history on record for this holder in this stock. | ||||||